Gastroenterology

Gastroenterology

Volume 109, Issue 3, September 1995, Pages 671-680
Gastroenterology

Alimentary tract
Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time

https://doi.org/10.1016/0016-5085(95)90373-9Get rights and content

Abstract

Background & Aims: It has been suggested that irritable bowel syndrome (IBS) and functional dyspepsia represent the same disease entity, the irritable gut. The aim of this study was to test the stability, consistency, and relevance of the current classification in the entire, unselected population of persons with gastrointestinal and/or abdominal symptoms, including those who had not consulted physicians. Methods: Sequential postal questionnaires were sent to 1290 representative persons (age range, 20–79 years) sampled from the population. Questions were asked about the prevalence of 24 gastrointestinal and/or abdominal symptoms and the site and type of abdominal pain, if any. Results: The prevalence of dyspepsia was 14% (32% if predominant reflux symptoms and concomitant IBS symptoms were included), and the prevalence of IBS was 12.5%. The 3-month incidence rates of reflux, dyspepsia, and IBS among previously symptomless persons were 0.5, 8, and 2 per 1000, respectively. Of persons with IBS, 87% also fulfilled the dyspepsia criteria, and the overlap between dyspepsia subgroups was more than 50%. The use of stricter criteria did not eliminate this overlap. Over a 1-year period, approximately 50% changed their symptom profile. Principal component analysis did not show any natural clustering of the symptoms. Conclusions: The separation of functional gastrointestinal symptoms into dyspepsia, its subgroups, and IBS may be inappropriate.

References (53)

  • NJ Talley et al.

    Functional dyspepsia: a classification with guidelines for diagnoses and management

    Gastroenterol Int

    (1991)
  • AP Manning et al.

    Towards positive diagnosis of the irritable bowel

    BMJ

    (1978)
  • DA Drossman et al.

    Identification of sub-groups of functional gastrointestinal disorders

    Gastroenterol Int

    (1990)
  • G Dotevall et al.

    Symptoms in irritable bowel syndrome

    Scand J Gastroenterol

    (1982)
  • H Hollnagel et al.

    Mave-tarmsymptomer blandt 40-årige i Glostrup: en epidemiologisk undersøgelse

    Ugeskr Laeger

    (1982)
  • NJ Talley et al.

    The association between non-ulcer dyspepsia and other gastrointestinal disorders

    Scand J Gastroenterol

    (1985)
  • F Sielaff

    Coincidence between chronic dyspepsia and irritable bowel syndrome

    Eur J Gastroenterol Hepatol

    (1990)
  • NJ Talley

    Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome

    Scand J Gastroenterol

    (1991)
  • R Johnsen et al.

    Prevalences of endoscopic and histological findings in subjects with and without dyspepsia

    BMJ

    (1991)
  • T Johannessen et al.

    The intensity and variability of symptoms in dyspepsia

    Scand J Prim Health Care

    (1993)
  • NJ Talley et al.

    Discriminant value of dyspeptic symptoms and dyspepsia subgroups in functional dyspepsia

    Gastroenterology

    (1992)
  • L Agréus

    Socio-economic factors, health care consumption and rating of abdominal symptom severity

  • GW Welch et al.

    Specificity of psychological profiles of irritable bowel syndrome patients

    Aust N Z J Med

    (1984)
  • I Sjödin et al.

    Psychological aspects of non-ulcer dyspepsia: a psychosomatic view focusing on a comparison between the irritable bowel syndrome and peptic ulcer disease

    Scand J Gastroenterol

    (1985)
  • R Johnsen et al.

    Associations between symptoms of irritable colon and psychological and social conditions and lifestyle

    BMJ

    (1986)
  • PJ Whorwell et al.

    Oesophageal motility in the irritable bowel syndrome

    BMJ

    (1981)
  • Cited by (648)

    • Functional Bowel Disease

      2021, Clinics in Geriatric Medicine
    • Functional gastrointestinal disorders: advances in understanding and management

      2020, The Lancet
      Citation Excerpt :

      FGIDs are chronic conditions. Although symptoms fluctuate, and are often related to meals,56,57 prevalence of symptom reporting tends to remain the same, given that the number of people whose symptoms disappear are matched by the number of people who develop new-onset symptoms.63–65 The development of new-onset symptoms in people who were previously asymptomatic might reflect bidirectional gut–brain pathways, with higher anxiety and depression associated with development of IBS and functional dyspepsia during follow-up.44,45,66

    View all citing articles on Scopus

    Supported by the Medical Faculty of Uppsala University, Uppsala County Council, and Astra Pharmaceutical.

    View full text